We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+16.26%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$381M
AUM Growth
-$24.2M
Cap. Flow
-$64.4M
Cap. Flow %
-16.91%
Top 10 Hldgs %
75.56%
Holding
25
New
4
Increased
5
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
FTRE icon
Fortrea Holdings
FTRE
+$7.57M
2
CMPS
Compass Pathways
CMPS
+$4.2M
3
GH icon
Guardant Health
GH
+$3.92M
4
SRRK icon
Scholar Rock
SRRK
+$3.28M
5
EXAS
Exact Sciences
EXAS
+$2.36M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$23.9M
2
INSM icon
Insmed
INSM
+$19.2M
3
UNH icon
UnitedHealth
UNH
+$19M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$9.12M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.37M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
1
argenx
ARGX
$54.2B
$57.1M 14.99%
77,430
– –
INSM icon
2
Insmed
INSM
$29.5B
$39.1M 10.27%
271,600
-157,000
-37% -$19.2M
NTRA icon
3
Natera
NTRA
$46.4B
$32.8M 8.61%
203,664
-32,300
-14% -$5.11M
ICLR icon
4
Icon
ICLR
$12.9B
$32M 8.39%
182,590
-20,200
-10% -$3.38M
ILMN icon
5
Illumina
ILMN
$29B
$30.6M 8.03%
322,261
-21,100
-6% -$2.09M
NBIX icon
6
Neurocrine Biosciences
NBIX
$16.7B
$22.9M 6%
162,800
-54,400
-25% -$7.37M
RARE icon
7
Ultragenyx Pharmaceutical
RARE
$2.65B
$21M 5.5%
697,000
+69,400
+11% +$2.08M
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$13.3B
$19.9M 5.22%
366,812
– –
GH icon
9
Guardant Health
GH
$22.8B
$17.8M 4.66%
284,100
+72,100
+34% +$3.92M
EXAS
10
DELISTED
Exact Sciences
EXAS
$14.8M 3.89%
270,950
+47,200
+21% +$2.36M
SRRK icon
11
Scholar Rock
SRRK
$6.21B
$13.5M 3.55%
363,300
+93,900
+35% +$3.28M
BBIO icon
12
BridgeBio Pharma
BBIO
$16.7B
$13.5M 3.54%
259,300
– –
PRCT icon
13
Procept Biorobotics
PRCT
$1.26B
$11M 2.89%
308,434
+9,345
+3% +$427K
ALNY icon
14
Alnylam Pharmaceuticals
ALNY
$29B
$10.8M 2.84%
23,686
-22,400
-49% -$9.12M
AKRO
15
DELISTED
Akero Therapeutics
AKRO
$10.7M 2.82%
226,400
– –
AGIO icon
16
Agios Pharmaceuticals
AGIO
$1.94B
$9.88M 2.59%
246,230
-84,600
-26% -$3.18M
FTRE icon
17
Fortrea Holdings
FTRE
$1.81B
$8.33M 2.19%
+988,772
New +$7.57M
CMPS
18
Compass Pathways
CMPS
$1.79B
$5.36M 1.41%
+935,450
New +$4.2M
CNTA
19
DELISTED
Centessa Pharmaceuticals
CNTA
$2.5M 0.66%
+103,100
New +$1.83M
ALKS icon
20
Alkermes
ALKS
$8.27B
$2.45M 0.64%
+81,800
New +$2.31M
ISRG icon
21
Intuitive Surgical
ISRG
$138B
$1.96M 0.52%
4,390
– –
IMCR icon
22
Immunocore
IMCR
$1.73B
$1.68M 0.44%
46,300
– –
VIR icon
23
Vir Biotechnology
VIR
$1.5B
$1.37M 0.36%
240,500
– –
DXCM icon
24
DexCom
DXCM
$33.2B
– –
-273,821
Closed -$23.9M
UNH icon
25
UnitedHealth
UNH
$371B
– –
-60,888
Closed -$19M

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Eagle Health Investments held 25 positions worth $381M, down 6% from $405M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Eagle Health Investments withdrew a net $64.4M in Q3 2025, closing 2 positions and reducing 7 holdings. Its most notable exit was DexCom, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Eagle Health Investments opened a new position in Fortrea Holdings worth $8.33M.

  • Eagle Health Investments's largest Q3 2025 buy was Fortrea Holdings: 988,772 shares worth $8.33M.
  • Eagle Health Investments added most to Guardant Health in Q3 2025, an estimated $3.92M increase.
  • Eagle Health Investments's biggest Q3 2025 reduction was Insmed, cutting an estimated $19.2M.
  • Eagle Health Investments fully exited DexCom in Q3 2025, selling an estimated $23.9M.
  • Eagle Health Investments's ten largest holdings make up 76% of its $381M portfolio in Q3 2025.
  • Eagle Health Investments opened 4 new positions and closed 2 in Q3 2025.
  • Eagle Health Investments's portfolio value fell 6% quarter-over-quarter to $381M.

Based on Eagle Health Investments's 13F filing for Q3 2025, filed 7 Nov 2025.